Clinical Trials on HER-2 Positive Metastatic Breast Cancer in Korea, Democratic People's Republic of
Total 158 results
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
National Cancer Center, KoreaActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of
-
Samsung Medical CenterNot yet recruitingPremenopausal HR+/HER2- Metastatic Breast CancerKorea, Republic of
-
Gangnam Severance HospitalSeoul National UniversityRecruitingBreast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive Tumor | Premenopausal Breast Cancer | Node-positive Breast CancerKorea, Republic of
-
Sung Yong OhCelltrionUnknownMetastatic Cancer | HER-2 Positive Gastric CancerKorea, Republic of
-
Asan Medical CenterHoffmann-La RocheCompletedMetastatic or Recurrent Gastric Adenocarcinoma | Her-2 Positive Gastric CancerKorea, Republic of
-
Yonsei UniversityRecruitingTriple Negative Breast Cancer | Metastatic Breast Cancer With HER2 PositiveKorea, Republic of
-
Alteogen, Inc.CompletedHER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterUnknownHER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterAsan Medical Center; Seoul National University Hospital; Ulsan University Hospital and other collaboratorsUnknownMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Breast Cancer Nos PremenopausalKorea, Republic of
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
Samsung Medical CenterActive, not recruitingHER2-positive Breast Cancer | Chemotherapy Effect | Circulating Tumor DNAKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedNational OncoVentureCompletedHER-2 Positive Advanced Gastric CancerKorea, Republic of
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Korea University Guro HospitalKorean Cancer Study GroupActive, not recruitingMetastatic Cancer | HER2 Gene MutationKorea, Republic of
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Severance HospitalRecruitingBreast Cancer | Surgery | Recurrent Breast Cancer | Estrogen Receptor Positive Tumor | Stereotactic Body Radiotherapy | Her2-negative TumorKorea, Republic of
-
Samsung Medical CenterCompletedHER2-positive Refractory Advanced CancerKorea, Republic of
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Yonsei UniversityCompletedHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Eli Lilly and CompanyCompletedHER-2 Positive Breast Cancer | Hormone Receptor Positive Breast CancerSpain, United States, Korea, Republic of, Belgium, France, Germany, Italy, Australia, Argentina, Canada, United Kingdom, Mexico, Brazil, Greece
-
Seoul National University HospitalActive, not recruitingHormone Receptor-positive Breast Cancer | Premenopausal Breast CancerKorea, Republic of
-
Seoul National University HospitalActive, not recruitingInvasive Breast Cancer | Estrogen Receptor Positive Breast CancerKorea, Republic of
-
Olema Pharmaceuticals, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2 Negative Breast Carcinoma | ER Positive Breast CancerUnited States, Korea, Republic of, Australia, Taiwan, Hong Kong, Malaysia, Thailand, Argentina, Belgium, Portugal, Italy
-
Samsung Medical CenterRecruitingMetastatic Breast CancerKorea, Republic of
-
Seoul National University HospitalSeoul National University Bundang Hospital; Korean Cancer Study Group (KCSG); Eisai Korea Inc... and other collaboratorsActive, not recruitingMetastatic Breast CancerKorea, Republic of
-
Samsung Medical CenterUnknownBreast Cancer MetastaticKorea, Republic of
-
Samsung Medical CenterUnknownMetastatic Breast CancerKorea, Republic of
-
National Cancer Center, KoreaCompletedGoserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBCMetastatic Breast CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownMetastatic Breast CancerKorea, Republic of
-
Korea University Guro HospitalRecruitingMetastatic Breast CancerKorea, Republic of
-
Yonsei UniversityNot yet recruiting
-
Asan Medical CenterEisai Inc.; Dong-A ST Co., Ltd.; Samyang Biopharmaceuticals CorporationCompletedMetastatic Breast CancerKorea, Republic of
-
Samsung Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
CelltrionUnknownMetastatic Breast CancerKorea, Republic of
-
Gachon University Gil Medical CenterUnknownMetastatic Breast CancerKorea, Republic of
-
Changhoon YooCompletedCholangiocarcinoma | Biliary Tract Cancer | HER-2 Gene Amplification | HER-2 Protein OverexpressionKorea, Republic of
-
PfizerActive, not recruiting
-
Yonsei UniversityCompletedMetastatic Breast CancerKorea, Republic of
-
Gencurix, Inc.RecruitingEarly Hormone Receptor-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Radiation Therapy ComplicationKorea, Republic of
-
Asan Medical CenterCompletedMetastatic Breast CancerKorea, Republic of
-
Samsung Medical CenterCompletedHER2-positive Gastric Cancer Patients With Liver MetastasisKorea, Republic of
-
Gangnam Severance HospitalRecruitingHER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 StudyKorea, Republic of
-
National Cancer Center, KoreaTerminatedMetastatic Breast CancerKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownMetastatic Breast Cancer | Recurrent Breast CancerKorea, Republic of
-
AstraZenecaCompletedER+ HER2- Advanced Breast CancerUnited States, United Kingdom, Korea, Republic of